Radiation Therapy in the Management of Adrenal Metastases

Semin Radiat Oncol. 2023 Apr;33(2):193-202. doi: 10.1016/j.semradonc.2022.11.001.

Abstract

Adrenal glands represent a common site of metastases from several primary tumors, including lung cancer, breast cancer and melanoma. Surgical resection is considered the standard of care, but surgery is not always feasible given the challenges related to anatomical site and/or due to patient and/or disease characteristics. Stereotactic body radiation therapy (SBRT) represents a promising treatment for oligometastases, though the literature on its role for adrenal metastases is still heterogeneous. Herein are summarized the most relevant published studies on the efficacy and safety of SBRT for adrenal gland metastases. The preliminary data suggests that SBRT yields high local control rates and symptom relief with a mild pattern of toxicity. Advanced radiotherapy techniques including IMRT and VMAT, a BED10 > 72 Gy and the use of 4DCT for motion control should be considered for a high quality ablative treatment of adrenal gland metastases.

Publication types

  • Review

MeSH terms

  • Adrenal Gland Neoplasms* / pathology
  • Adrenal Gland Neoplasms* / radiotherapy
  • Adrenal Gland Neoplasms* / secondary
  • Dose Fractionation, Radiation
  • Humans
  • Lung Neoplasms* / pathology
  • Radiosurgery* / methods